Tag: musculoskeletal

Treatment Reduces Diabetes Risk in People With Rheumatoid Arthritis

Cynthia A. Lockley on

From the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), February 2008.

"Antirheumatic, Antimalarial Treatment Reduces Diabetes Risk in People With Rheumatoid Arthritis":

Researchers partly funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) recently found that hydroxychloroquine, a medication used to treat rheumatic diseases and malaria, reduced the incidence of diabetes in people with rheumatoid arthritis (RA). RA is an inflammatory disease that causes pain, swelling, stiffness and loss of function in the joints.

See the full archived article at https://www.archive.niams.nih.gov/spotlight-on-research/2008/antirheumatic-antimalarial-treatment-rheumatoid-arthritis  Updated

Lupus

Cynthia A. Lockley on
  • Lupus Foundation of America, Inc. We are devoted to solving the mystery of lupus, one of the world's cruelest, most unpredictable, and devastating diseases, while giving caring support to those who suffer from its brutal impact.
  • Lupus Family Registry and Repository (LFRR) formerly the Lupus Multiplex Registry and Repository (LMRR), is a long-term research project operating in conjunction with the Lupus Genetics Studies. LFRR is sponsored by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a branch of the National Institutes of Health (NIH).  Updated